Effect of transurethral resection on serum free/total prostate-specific antigen levels in patients with benign prostatic hyperplasia

Urology

Volumn 53, Issue 1, 1999, Pages 118-120

  Çetinkaya, Mesut ^a   Ulusoy, Ercüment ^a   Aki, Tuncay ^a   Koşan, Murat ^a   Kundak, Çagatay ^a   Aydos, M Murat ^a   Gökkaya, Serkan ^a  

^a ANKARA NUMUNE HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CLINICAL TRIAL; ENZYME IMMUNOASSAY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE DISEASE; PROSTATE HYPERTROPHY; PROSTATE SURGERY; TRANSURETHRAL RESECTION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC HYPERPLASIA; REPRODUCIBILITY OF RESULTS; URINARY BLADDER NECK OBSTRUCTION;

EID: 0032950763     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00426-9     Document Type: Article

References (19)

1. Catalona W.J., Smith D.S., Ratliff T.L., et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med. 324:1991;1156-1161.
2. Mettlin C., Lee F., Drago J., et al. Findings on the detection of early prostate cancer in 2425 men. Cancer. 67:1991;2949-2958.
3. Oesterling J.E. Prostate-specific antigen a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate . J Urol. 145:1991;907-923.
4. Hasui Y., Marutsuka K., Asada Y., et al. Relationship between serum prostate-specific antigen and histological prostatitis in patients with benign prostatic hyperplasia. Prostate. 25:1994;91-96.
5. Oesterling J.E., Rice D.C., Glenski W.J., et al. Effect of cystoscopy, prostate biopsy, and transurethral resection of prostate on serum prostate-specific antigen concentration. Urology. 42:1993;276-282.
6. Sershon P.D., Barry M.J., Oesterling J.E. Serum PSA values in men with histologically confirmed BPH versus patients with organ-confined prostate cancer (abstract). J Urol. 149:1993;421A.
7. Oesterling J.E., Jacobsen S.J., Chute C.G., et al. Serum prostate-specific antigen in a community-based population of healthy men establishment of age-specific reference ranges . JAMA. 270:1993;860-864.
8. Benson M.C., Whang I.S., Olsson C.A., et al. The use of prostate specific antigen density (PSAD) to enhance the predictive value of intermediate levels of serum PSA. J Urol. 147:1992;817-821.
9. Carter H.B., Pearson J.D., Waclawiw Z., et al. Prostate-specific antigen variability in men without prostate cancer the effect of sampling interval and number of repeated measurements on prostate-specific antigen velocity . Urology. 45:1995;591-596.
10. Stenman U.H., Leinonen J., Alfthan H., et al. A complex between prostate-specific antigen and alpha-1-antichymotrypsin is the major form of the prostate-specific antigen in serum of patients with prostatic cancer assay of the complex improves clinical sensitivity for cancer . Cancer Res. 51:1991;222-226.
11. Christensson A., Laurell C.B., Lilja H. Enzymatic activity of prostate-specific antigen and its reaction with extracellular serine proteinase inhibitors. Eur J Biochem. 194:1990;755-763.
12. 1-antichymotrypsin as an indicator of prostate cancer. J Urol. 150:1993;100-105.
13. Luderer A.A., Chen Y.T., Soriano T.F., et al. Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen. Urology. 46:1995;187-194.
14. Oesterling J.E., Wojno J.K., England B., et al. A comparison of free to total PSA (F/T) ratio to total PSA for distinguishing benign prostatic hyperplasia (BPH) from prostate cancer (CaP) using the Abbott AxSYM system. J Urol. 155:1996;370-376.
15. Catalona W.J., Smith D.S., Wolfert R.L., et al. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA. 274:1995;1214-1220.
16. Oesterling J.E., Jacobsen S.J., Klee G.G., et al. Free, complexed, and total serum PSA the establishment of appropriate reference ranges for concentrations and ratios . J Urol. 154:1995;1090-1095.
17. Yemoto C.M., Nolley R., Prestigiacomo A.F., et al. Free (f) and total (t) PSA density in patients with prostate cancer (CaP) and benign prostatic hyperplasia (BPH) (abstract). J Urol. 155:1996;374A.
18. Bjartell A., Björk T., Matikainen M.T., et al. Production of alpha-1-antichymotripsin by PSA-containing cells of the human prostate epithelium. Urology. 42:1993;502-510.
19. Björk T., Bjartell A., Abrahamsson P.A., et al. Alpha-1-antichymotrypsin production in PSA-producing cells is common in prostate cancer but rare in benign prostatic hyperplasia. Urology. 43:1994;427-434.